Markets

Insider Trading

Hedge Funds

Retirement

Opinion

1281292 - 11759070 - 1

10 Best Stocks to Buy According to Billionaire Bill Gates

Page 1 of 4

In this article, we will discuss the 10 Best Stocks to Buy According to Billionaire Bill Gates.

There are far too many urgent problems to solve rather than holding onto resources that could help people. It is a sentiment echoed by billionaire investor Bill Gates, who reiterated plans to ramp up philanthropic activities last May with plans to give away $200 billion over the next two decades.

True to his word, Gates has tweaked his exposure to equity markets over the past year through the Bill & Melinda Gates Foundation Trust, aiming to raise capital for philanthropic work.

“That is why I have decided to give my money back to society much faster than I had originally planned,” Gates wrote in announcing his philanthropic plans last May.

Once the richest person in the world, Gates has exited all his holdings in Microsoft following the sale of 7.7 million shares for about $3.2 billion.

Following the sale, Gates has diversified his holdings into some of the biggest names known for their bumper dividend payouts in pursuit of passive income. Alongside the high-profile names, Gates has also spread market risk across a few under-the-radar names.

The Gate’s Trust is best known for value investing, which favors large, established companies with a strong competitive edge. In addition, it focuses on growth stocks with tremendous long-term prospects, strongly influenced by Warren Buffett, one of the foundation’s largest donors.

With that in mind, let’s take a look at some of the best stocks to buy according to billionaire Bill Gates.

Bill Gates

Our Methodology

To compile this list of the 10 best stocks to buy according to billionaire Bill Gates, we began by scanning Bill & Melinda Gates Foundation Trust’s 13F portfolio as of the end of Q1 2026. Next, we analyzed the hedge fund’s top 20 stock holdings to identify stocks with at least 10% upside potential. We then reviewed hedge fund sentiment around these stocks using Insider Monkey’s database of Q1 2026 13F filings, which tracks the number of hedge funds holding each security. Finally, the stocks were ranked in ascending order based on the value of the Bill & Melinda Gates Foundation Trust’s stake in each company.

“Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Insider Monkey’s quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 599.2% since May 2014, beating its benchmark by 372 percentage points (see more details here).”

Best Stocks to Buy According to Billionaire Bill Gates

10. McDonald’s Corp (NYSE:MCD)

Bill & Melinda Gates Foundation Trust Equity Stake: $104.1 Million

Number of Hedge Fund Holders: 83

Stock Upside Potential: 21.11%

McDonald’s Corp (NYSE:MCD) is one of the best stocks to buy according to billionaire Bill Gates. Analysts see more than 20% upside potential on MCD stock from the current level.

On June 1, McDonald’s Corp (NYSE:MCD) unveiled a new set of strategies designed to drive the next phase of its growth. The plan is called McDonald’s NEXT. This plan focuses on raising standards for hospitality, increasing automation, making food items taste better, and expanding social media marketing.

All this is part of an effort to make McDonald’s customers’ first choice. It turns out that the chain lost favor with some customers in recent years. According to a survey from UBS Evidence Labs, 55% of US customers in 2020 said McDonald’s offered good value. That dropped to roughly 44% in 2024 and has largely remained at that level.

McDonald’s NEXT plan aims to bring in more customers and encourage customers to visit McDonald’s locations more often. Additionally, this plan aims to make McDonald’s stores easier to run for franchisees. The restaurant chain’s previous corporate strategy was unveiled in 2020, and it focused on digital sales and marketing.

Earlier on May 21, McDonald’s declared a quarterly dividend of $1.86 per share, payable June 16, 2026, to shareholders of record on June 2 with an ex‑dividend date of June 1; the annualized payout of $7.44 represents a 2.7% yield.

McDonald’s Corp (NYSE:MCD) operates a fast-food restaurant chain. It has thousands of restaurant locations across more than 100 countries. McDonald’s restaurants serve a wide variety of food items, including burgers, chicken, fries, and beverages, to millions of customers every day.

9. West Pharmaceutical Services Inc (NYSE:WST)

Bill & Melinda Gates Foundation Trust Equity Stake: $111.4 Million

Number of Hedge Fund Holders: 50

Stock Upside Potential: 13.49%

West Pharmaceutical Services Inc (NYSE:WST) is one of the best stocks to buy according to billionaire Bill Gates. WST stock is up around 14% year-to-date and has gained nearly 50% over the past year. Analysts still see upside potential in the stock.

On May 31, Wolfe Research initiated coverage of West Pharmaceutical Services Inc (NYSE:WST) stock with an Outperform rating and a price target of $375. The brokerage based its decision on the company’s business fundamentals and valuation history.

Based on Wolfe Research’s earnings estimates for West Pharmaceutical Services, the price target represents 40 times projected EPS for 2027. According to the firm, WST stock has typically traded around 40 times earnings over the past 15 years.

Additionally, the firm noted that West Pharmaceutical has historically commanded a premium of more than 100% to the S&P 500. Furthermore, the firm pointed out that even when compared with companies in its own sector, West Pharmaceutical’s stock has historically traded at a substantial premium of 75%.

Therefore, Wolfe Research sees its valuation for West Pharmaceutical stock as supported by both historical trading patterns and the outlook for future earnings growth.

West Pharmaceutical Services Inc (NYSE:WST) manufactures packaging and delivery systems for injectable medicines. Its portfolio includes rubber stoppers, seals, plungers, prefilled syringes, and self-injection devices. Pharmaceutical and biotechnology companies use these components to safely store and administer drugs.

Page 1 of 4

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a month later!

 

Wall Street calls this $3 stock a “Melting Ice Cube.” They said the same thing about BTI before it returned 90%.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.